• Piri Keşif Aracı

Arama ipuçları nelerdir?
1.  sayfa ve
1
New Coronavirus COVID-19 (SARS-CoV-2)
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Detskie Infekcii (Moskva)
Yazar(lar) :
O. V. Shamsheva
Yıl :
2020
New Coronavirus COVID-19 (SARS-CoV-2) covid-19 (sars-cov-2)
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
30 января 2020 года Всемирная Организация Здравоохранения (ВОЗ) признала вспышку коронавирусной инфекции в Китае чрезвычайной ситуацией в области общественного здравоохранения, имеющую международное значение. Генеральный директор ВОЗ Тедрос Адханом Гебрейесус после совещания чрезвычайного комитета в Женеве заявил «Я объявляю международную чрезвычайную ситуацию в области общественного здравоохранения из-за глобальной вспышки коронавируса». В классификации ВОЗ такими ситуациями считаются «экстраординарные события, которые будут представлять риск в области здравоохранения другим государствам» и потенциально требуют скоординированных действий международного сообщества. Как говорится в заявлении ВОЗ, распространение вируса возможно остановить, если страны мира примут меры по раннему распознаванию коронавируса, изолируют больных и отследят контакты.
DOI : 10.22627/2072-8107-2020-19-1-5-6
Anahtar Kelimeler : covid-19 (sars-cov-2)
ISSN: 2072-8107
Cilt: 19
Sayı: 1
Sayfa: 5 - 6
2
SARS-CoV-2 neutralizing antibody development strategies
Araştırma Makalesi

Araştırma Makalesi
Open Access
Kaynak :
Aperta - TÜBİTAK Açık Arşivi
Dergi:
TURKISH JOURNAL OF BIOLOGY
Yazar(lar) :
Aylin Ozdemir Bahadir , Saban Tekin , Hivda Ulbegi Polat , Muge Serhatli , Filiz Kaya , Fatima Yucel , Hasan Umit Ozturk , Melis Denizci Oncu , Bertan Koray Balcioglu
Yıl :
2020
SARS-CoV-2 neutralizing antibody development strategies Owing to a high rate of transmission from human to human, the new virus called SARS- CoV- 2 differed from others by its unexpectedly rapid spread. No approved targeted-therapies are available for COVID- 19, yet. This review aims to provide some of the neutralizing antibody development strategies for SARS- CoV- 2 and in vitro and in vivo neutralization assays.
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health Organization (WHO) described the most recent coronavirus epidemic as a global pandemic in March 2020. The virus spread triggered a health crisis (the COVID-19 disease) within three months, with socioeconomic implications. No approved targeted-therapies are available for COVID-19, yet. However, it is foreseen that antibody-based treatments may provide an immediate cure for patients. Current neutralizing antibody development studies primarily target the S protein among the structural elements of SARS-CoV-2, which mediates the cell entry of the virus through the angiotensin converting enzyme 2 (ACE2) receptor of host cells. This review aims to provide some of the neutralizing antibody development strategies for SARS-CoV-2 and in vitro and in vivo neutralization assays.
DOI : 10.3906/biy-2005-91
Sayi :44
issue :3
Sayfa :203-214
Sınıflandırma :
Biyotıp %100
Viroloji %100
3
Novel Coronavirus (SARS-CoV-2) Pandemic: Overview and Current Status
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Yazar(lar) :
Şehnaz ALP , Serhat ÜNAL
Yıl :
2020
Novel Coronavirus (SARS-CoV-2) Pandemic: Overview and Current Status The disease was later named as COVID- 19 ( coronavirus disease 2019) and the causative agent was designated as SARS- CoV- 2 (severe acute respiratory syndrome coronavirus 2). The knowledge on the characteristics and epidemiology of SARS- CoV- 2 and COVID- 19 has been increasing day by day. severe acute respiratory syndrome coronavirus 2 sars-cov-2 covid-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
In the end of December 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, China. The disease was later named as COVID-19 (coronavirus disease 2019) and the causative agent was designated as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Even though the disease was suggested to be of zoonotic origin, human to human spread was also described and became the main mode of transmission. The number of cases significantly increased within a short period of time and the disease spread worldwide. On March 11, 2020, the World Health Organization announced COVID-19 outbreak as a pandemic. As of May 6, 2020, it has been reported that there are 3.588.773 people diagnosed with COVID-19 among 215 countries, territories or areas, and 247.503 people have died from the disease. In our country, the first case was identified on March 10, 2020, and the first death from the disease was reported on March 17, 2020. According to the data announced on May 6, 2020, the total number of cases detected in our country was 131.744, and the number of deaths related to the disease was 3584. The knowledge on the characteristics and epidemiology of SARS-CoV-2 and COVID-19 has been increasing day by day. Sequence analysis of the viral genome enabled the development of diagnostic tests and facilitated the initiation of research on both therapeutic options and vaccine development. In this review article, current information on the biology, epidemiology, clinical features, diagnosis, treatment, and prevention of SARS-CoV-2 and COVID-19 was discussed.
DOI : 10.5578/flora.69574
Anahtar Kelimeler : severe acute respiratory syndrome coronavirus 2, sars-cov-2, coronavirus disease-2019, covid-19, novel coronavirus
ISSN: 1300-932X
Cilt: 25
Sayı: 2
Sayfa: 111 - 120
Sınıflandırma :
4
Epidemiology of SARS-CoV-2: numbers matter!
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Pediatric and Neonatal Individualized Medicine
Yazar(lar) :
Giorgia Casti , Pier Paolo Bassareo , Marco Limone , Filippo Pistolesi , Vassilios Fanos , Maria Antonietta Marcialis
Yıl :
2020
Epidemiology of SARS-CoV-2: numbers matter! The ongoing pandemic is the result of the spread of a recently identified Coronavirus, named SARS- CoV- 2 (Severe Acute Respiratory Syndrome – Coronavirus – 2). Since 31th December 2019, when the first cluster was reported in Wuhan (China), the global Novel COronaVIrus Disease 2019 ( COVID- 19) cases significantly covid-19 sars-cov-2 coronavirus
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The ongoing pandemic is the result of the spread of a recently identified Coronavirus, named SARS-CoV-2 (Severe Acute Respiratory Syndrome – Coronavirus – 2). Since 31th December 2019, when the first cluster was reported in Wuhan (China), the global Novel COronaVIrus Disease 2019 (COVID-19) cases significantly increased, and on 12th March 2020, the WHO Director declared the disease as pandemic. As of April 28th 2020, 2.982,688 cases and 210,193 deaths were reported globally. The aim of this article is the analysis of the main epidemiological characteristics of the current pandemic: transmission, basic reproduction number (R0), incubation period, global, European and Italian confirmed cases and deaths, focusing on the paediatric population.
DOI : 10.7363/090203
Anahtar Kelimeler : covid-19, sars-cov-2, 2019-ncov, coronavirus, epidemiology, children, review
ISSN: 2281-0692
Cilt: 9
Sayı: 2
Sayfa: e090203 - e090203
Sınıflandırma :
5
Meningoencephalitis from SARS-CoV-2 infection
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
IDCases
Yazar(lar) :
Fatima Hafizi , Saleema Kherani , Madeeha Shams
Yıl :
2020
Meningoencephalitis from SARS-CoV-2 infection The current global pandemic of COVID- 19 disease is caused by a novel coronavirus SARS- CoV- 2. We report a case of a 35-year-old woman with meningoencephalitis associated with COVID- 19 disease who presented with altered mental status and rhythmic Although rare, meningoencephalitis should be considered as a possible manifestation of COVID- 19 disease. COVID-19 SARS-CoV-2 Coronavirus
Yayıncı Web Sitesi
Kaydet Alıntıla
The current global pandemic of COVID-19 disease is caused by a novel coronavirus SARS-CoV-2. This typically causes severe respiratory illness, however, as cases have multiplied across the globe, protean manifestations involving multiple organ systems have been described. We report a case of a 35-year-old woman with meningoencephalitis associated with COVID-19 disease who presented with altered mental status and rhythmic limb movements. Although rare, meningoencephalitis should be considered as a possible manifestation of COVID-19 disease.
Anahtar Kelimeler : COVID-19, SARS-CoV-2, Coronavirus, Meningoencephalitis, Nervous system
ISSN: 2214-2509
Cilt: 21
Sayfa: e00919
Sınıflandırma :
6
Assessing Immune Response to SARS-CoV-2 Infection
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
ImmunoTargets and Therapy
Yazar(lar) :
Shurin MR , Morris A , Wells A , Wheeler SE
Yıl :
2020
Assessing Immune Response to SARS-CoV-2 Infection In 2002, the first known case of severe acute respiratory syndrome ( SARS) occurred in China and SARS coronavirus ( SARS- CoV) was identified in 2003.1 Before The World Health Organization (WHO) on March 11, 2020, declared coronavirus disease 2019 ( COVID- 19) caused by severe acute respiratory syndrome coronavirus 2 ( SARS- CoV- 2) a pandemic. sars-cov-2 covid-19 coronavirus
Yayıncı Web Sitesi
Kaydet Alıntıla
Michael R Shurin,1,2 Alison Morris,3 Alan Wells,1 Sarah E Wheeler1 1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 2Department of Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 3Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USACorrespondence: Michael R Shurin Email shurinmr@upmc.eduIn the XXI century, we have already witnessed the global spread of three previously unknown coronaviruses. In 2002, the first known case of severe acute respiratory syndrome (SARS) occurred in China and SARS coronavirus (SARS-CoV) was identified in 2003.1 Before SARS pandemic was declared to be over in summer of 2003, about 8500 cases were reported, including almost 900 deaths in 32 countries. Ten years later, in 2012, a novel coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), was isolated and was proven to be associated with several clusters of cases, first in the Arabian Peninsula and then in other countries. As a result, almost 2500 cases including more than 850 deaths in 27 countries have been reported.2 In 2019, a novel β-coronavirus caused severe and even fatal pneumonia in Wuhan China, and rapidly spread to other provinces of China and other countries in 2020. The World Health Organization (WHO) on March 11, 2020, declared coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) a pandemic. By mid-May 2020, more than 300,000 people have died and over 4,000,000 have been infected by the coronavirus in almost 200 countries and territories worldwide.
Anahtar Kelimeler : sars-cov-2, covid-19, serology, coronavirus, immunodiagnostics
ISSN: 2253-1556
Cilt: 9
Sayfa: 111 - 114
Sınıflandırma :
7
Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Public Health
Yazar(lar) :
Bilal Javed , Bilal Javed , Abdullah Sarwer , Abdullah Sarwer , Erik B. Soto , Zia-ur-Rehman Mashwani
Yıl :
2020
Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health SARS-CoV-2 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.3389/fpubh.2020.00292
Anahtar Kelimeler : SARS-CoV-2, COVID-19, pandemic, mental health, stigma
ISSN: 2296-2565
Cilt: 8
Sınıflandırma :
8
RT‐LAMP for rapid diagnosis of coronavirus SARS‐CoV‐2
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Microbial Biotechnology
Yazar(lar) :
Wei E. Huang , Boon Lim , Chiau2010Chen Hsu , Dan Xiong , Wei Wu , Yejiong Yu , Huidong Jia , Yun Wang , Yida Zeng , Mengmeng Ji , Hong Chang , Xiuming Zhang , Hui Wang , Zhanfeng Cui
Yıl :
2020
RT‐LAMP for rapid diagnosis of coronavirus SARS‐CoV‐2 Summary The pandemic coronavirus SARS‐ CoV‐ 2 in the world has caused a large infected population suffering from COVID‐ 19. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of SARS‐ CoV‐ 2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of SARS‐ CoV‐ 2 in the regions of orf1ab, S gene and N gene.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Summary The pandemic coronavirus SARS‐CoV‐2 in the world has caused a large infected population suffering from COVID‐19. To curb the spreading of the virus, WHO urgently demanded an extension of screening and testing; thus, a rapid and simple diagnostic method is needed. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of SARS‐CoV‐2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of SARS‐CoV‐2 in the regions of orf1ab, S gene and N gene. A colorimetric change was used to report the results, which enables the outcome of viral RNA amplification to be read by the naked eye without the need of expensive or dedicated instrument. The sensitivity can be 80 copies of viral RNA per ml in a sample. We validated the RT‐LAMP method in a hospital in China, employing 16 clinic samples with 8 positives and 8 negatives. The testing results are consistent with the conventional RT‐qPCR. In addition, we also show that one‐step process without RNA extraction is feasible to achieve RNA amplification directly from a sample. This rapid, simple and sensitive RT‐LAMP method paves a way for a large screening at public domain and hospitals, particularly regional hospitals and medical centres in rural areas.
DOI : 10.1111/1751-7915.13586
ISSN: 1751-7915
Cilt: 13
Sayı: 4
Sayfa: 950 - 961
Sınıflandırma :
Viroloji %99
9
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Viruses
Yazar(lar) :
Nadin Younes , Duaa W. Al-Sadeq , Hadeel AL-Jighefee , Salma Younes , Ola Al-Jamal , Hanin I. Daas , Hadi. M. Yassine , Gheyath K. Nasrallah
Yıl :
2020
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 The recent outbreak of the Coronavirus disease 2019 ( COVID- 19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. - 19. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID- 19. COVID-19 SARS-CoV-2
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.
DOI : 10.3390/v12060582
Anahtar Kelimeler : COVID-19, SARS-CoV-2, viruses, diagnostic challenges, molecular testing, serology
ISSN: 1999-4915
Cilt: 12
Sayı: 582
Sayfa: 582
Sınıflandırma :
10
Neuromechanisms of SARS-CoV-2: A Review
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Neuroanatomy
Yazar(lar) :
Marcos F. DosSantos , Marcos F. DosSantos , Marcos F. DosSantos , Sylvie Devalle , Veronica Aran , Daniela Capra , Daniela Capra , Daniela Capra , Natália Roberta Roque , Juliana de Mattos Coelho-Aguiar , Tânia Cristina Leite de Sampaio e Spohr , Tânia Cristina Leite de Sampaio e Spohr , Janice Gonçalves Subilhaga , Cláudia Maria Pereira , Isabella D'Andrea Meira , Isabella D'Andrea Meira , Isabella D'Andrea Meira , Paulo Niemeyer Soares Filho , Vivaldo Moura-Neto , Vivaldo Moura-Neto , Vivaldo Moura-Neto , Vivaldo Moura-Neto , Vivaldo Moura-Neto
Yıl :
2020
Neuromechanisms of SARS-CoV-2: A Review Recent studies have suggested the neuroinvasive potential of severe acute respiratory coronavirus 2 ( SARS- CoV- 2). Notably, neuroinvasiveness might be involved in the pathophysiology of coronavirus disease 2019 ( COVID- 19). Here, we review the current literature that indicates that SARS- CoV- 2 can invade the nervous system. SARS-CoV-2 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Recent studies have suggested the neuroinvasive potential of severe acute respiratory coronavirus 2 (SARS-CoV-2). Notably, neuroinvasiveness might be involved in the pathophysiology of coronavirus disease 2019 (COVID-19). Some studies have demonstrated that synapse-connected routes may enable coronaviruses to access the central nervous system (CNS). However, evidence related to the presence of SARS-CoV-2 in the CNS, its direct impact on the CNS, and the contribution to symptoms suffered, remain sparse. Here, we review the current literature that indicates that SARS-CoV-2 can invade the nervous system. We also describe the neural circuits that are potentially affected by the virus and their possible role in the progress of COVID-19. In addition, we propose several strategies to understand, diagnose, and treat the neurological symptoms of COVID-19.
DOI : 10.3389/fnana.2020.00037
Anahtar Kelimeler : SARS-CoV-2, COVID-19, central nervous system, peripheral nervous system, anosmia, dysgeusia
ISSN: 1662-5129
Cilt: 14
Sınıflandırma :
11
Coronavirus-SARS-CoV-2: Biology and Problems in rRT-PCR Detection
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Borneo Journal of Pharmacy
Yazar(lar) :
Maelita Ramdani Moeis , Anis Puji Rahayu , Nisa Ihsani , Wulan Pertiwi
Yıl :
2020
Coronavirus-SARS-CoV-2: Biology and Problems in rRT-PCR Detection Coronavirus disease 2019 ( COVID- 19) first appeared in China in December 2019 and was declared a pandemic by the World Health Organization. COVID- 19 is caused by Severe Acute Respiratory Syndrome Corona Virus 2 ( SARS- CoV- 2), a new virus previously unknown to humans. covid-19 sars-cov-2
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Coronavirus disease 2019 (COVID-19) first appeared in China in December 2019 and was declared a pandemic by the World Health Organization. COVID-19 is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), a new virus previously unknown to humans. Here we look at what is known about this virus, the main method for detecting the presence of this virus in a person who is used as a golden standard, and the problems that could arise in this detection method. Understanding the biology of the virus and the strengths and weaknesses of the detection method are important for patient management and for overcoming the pandemic.
DOI : 10.33084/bjop.v3iSpecial-1.1429
Anahtar Kelimeler : covid-19, sars-cov-2, rrt-pcr, detection, false results
ISSN: 2621-4814
Cilt: 3
Sayı: Special-1
Sayfa: 136 - 145
Sınıflandırma :
Viroloji %93
12
The SARS-CoV-2 outbreak: What we know
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Infectious Diseases
Yazar(lar) :
Di Wu , Tiantian Wu , Qun Liu , Zhicong Yang
Yıl :
2020
The SARS-CoV-2 outbreak: What we know There is a current worldwide outbreak of the novel coronavirus Covid- 19 ( coronavirus disease 2019; the pathogen called SARS- CoV- 2; previously 2019-nCoV ), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus Coronavirus SARS-CoV-2 CoVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak from spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.
Anahtar Kelimeler : Coronavirus, SARS-CoV-2, CoVID-19, Epidemiology, Clinical features, Diagnosis
Cilt: 94
Sayfa: 44 - 48
Sınıflandırma :
13
Is SARS-CoV-2 Vertically Transmitted?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Pediatrics
Yazar(lar) :
Ana Cristina Simões e Silva , Caio Ribeiro Vieira Leal
Yıl :
2020
Is SARS-CoV-2 Vertically Transmitted? At the end of 2019, in Wuhan (China), the onset of a disease caused by severe acute respiratory syndrome coronavirus 2 ( SARS- CoV- 2) was observed. ,” “ COVID- 19,” and “vertical transmission.” Few studies about the vertical transmission of SARS- CoV- 2 are found in the literature. SARS-CoV-2 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
At the end of 2019, in Wuhan (China), the onset of a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was observed. The disease, named COVID-19, has a wide spectrum of clinical presentations, ranging from asymptomatic or mild to critical, and for some patients the disease is even fatal. Apparently, being a child or being pregnant does not represent an additional risk for adverse outcomes. The purpose of this mini-review was to investigate what is in the scientific literature, so far, in regard to vertical transmission of SARS-CoV-2. Data were obtained independently by the two authors, who carried out a systematic search in the PubMed, Embase, LILACS, Cochrane, Scopus and SciELO databases using the Medical Subject Heading terms “coronavirus,” “COVID-19,” and “vertical transmission.” Few studies about the vertical transmission of SARS-CoV-2 are found in the literature. In all case reports and case series, the mothers' infection occurred in the third trimester of pregnancy, there were no maternal deaths, and most neonates had a favorable clinical course. The virus was not detected in the neonate nasopharyngeal swab samples at birth, in the placenta, in the umbilical cord, in the amniotic fluid, in the breast milk or in the maternal vaginal swab samples in any of these articles. Only three papers reported neonatal SARS-CoV-2 infection, but there is a bias that positive pharyngeal swab samples were collected at 36 h and on the 2nd, 4th, and 17th days of life. The possibility of intrauterine infection has been based mainly on the detection of IgM and IL-6 in the neonates' serum. In conclusion, to date, no convincing evidence has been found for vertical transmission of SARS-CoV-2.
DOI : 10.3389/fped.2020.00276
Anahtar Kelimeler : SARS-CoV-2, COVID-19, vertical transmission, pregnant women, neonate, intrauterine infection
ISSN: 2296-2360
Cilt: 8
Sınıflandırma :
14
Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Environmental Research and Public Health
Yazar(lar) :
Andrea Maugeri , Martina Barchitta , Sebastiano Battiato , Antonella Agodi
Yıl :
2020
Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy ( SARS- CoV- 2) in all its regions. While such efforts are still ongoing, uncertainties regarding SARS- CoV- 2 transmissibility and ascertainment of cases make it difficult to evaluate the Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported SARS- CoV- 2 cases (18.4%; 95%CI = 0–34.0%) before 10 novel coronavirus COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Italy was the first country in Europe which imposed control measures of travel restrictions, quarantine and contact precautions to tackle the epidemic spread of the novel coronavirus (SARS-CoV-2) in all its regions. While such efforts are still ongoing, uncertainties regarding SARS-CoV-2 transmissibility and ascertainment of cases make it difficult to evaluate the effectiveness of restrictions. Here, we employed a Susceptible-Exposed-Infectious-Recovered-Dead (SEIRD) model to assess SARS-CoV-2 transmission dynamics, working on the number of reported patients in intensive care unit (ICU) and deaths in Sicily (Italy), from 24 February to 13 April. Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported SARS-CoV-2 cases (18.4%; 95%CI = 0–34.0%) before 10 March lockdown. Interestingly, we estimated that transmission rate in the community was reduced by 32% (95%CI = 23–42%) after the first set of restrictions, and by 80% (95%CI = 70–89%) after those adopted on 23 March. Thus, our estimates delineated the characteristics of SARS-CoV2 epidemic before restrictions taking into account unreported data. Moreover, our findings suggested that transmission rates were reduced after the adoption of control measures. However, we cannot evaluate whether part of this reduction might be attributable to other unmeasured factors, and hence further research and more accurate data are needed to understand the extent to which restrictions contributed to the epidemic control.
DOI : 10.3390/ijerph17144964
Anahtar Kelimeler : novel coronavirus, COVID-19, epidemic model, epidemiology
Cilt: 17
Sayı: 4964
Sayfa: 4964
Sınıflandırma :
15
Guillain-Barré syndrome and SARS-CoV-2
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Neurological Research and Practice
Yazar(lar) :
Anne Lampe , Alexander Winschel , Cornelie Lang , Thorsten Steiner
Yıl :
2020
Guillain-Barré syndrome and SARS-CoV-2 Abstract Since January 2020, after Chinese health authorities identified a new type of coronavirus ( SARS- CoV- 2), the virus has spread throughout China This article presents the case of a 65-years old man who was presumptively infected with SARS- CoV- 2 during his ski vacation in Austria in March 2020 and COVID-19 SARS-CoV-2
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Since January 2020, after Chinese health authorities identified a new type of coronavirus (SARS-CoV-2), the virus has spread throughout China and consecutively throughout the whole world. The most common symptoms include fever and respiratory tract symptoms. Nevertheless, some patients show less common symptoms such as gastrointestinal or neurological manifestations. This article presents the case of a 65-years old man who was presumptively infected with SARS-CoV-2 during his ski vacation in Austria in March 2020 and acutely presented with typical symptoms of Guillain-Barré syndrome.
DOI : 10.1186/s42466-020-00066-0
Anahtar Kelimeler : Guillain-Barré syndrome, COVID-19, SARS-CoV-2
ISSN: 2524-3489
Cilt: 2
Sayı: 1
Sayfa: 1 - 3
Sınıflandırma :
16
Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Madrileña de Salud Pública
Yazar(lar) :
Cristina Loras , Juan Carlos Sanz
Yıl :
2020
Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2 En diciembre de 2019 surgió en China un nuevo coronavirus, conocido como SARS- CoV- 2 y causante de la enfermedad COVID- 19. SARS- CoV que apareció a comienzo de este siglo en China y el MERS- CoV que surgió en Arabia en 2012. SARS- CoV- 2 empezó a propagarse en un mercado de la ciudad de Wuhan (China) donde se vendían pescados, mariscos y diferentes animales vivos. sars-cov-2 novel coronavirus covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
En diciembre de 2019 surgió en China un nuevo coronavirus, conocido como SARS-CoV-2 y causante de la enfermedad COVID-19. En pocas semanas se extendió por numerosos países. El objetivo de esta revisión es describir las características de este nuevo agente. Los coronavirus engloban a un grupo de virus en el que existen algunos que infectan a humanos, y de éstos los más importantes hasta la fecha han sido el SARS-CoV que apareció a comienzo de este siglo en China y el MERS-CoV que surgió en Arabia en 2012. SARS-CoV-2 empezó a propagarse en un mercado de la ciudad de Wuhan (China) donde se vendían pescados, mariscos y diferentes animales vivos. Presenta un ritmo reproductivo elevado y los estudios apuntan a que el reservorio primario son los murciélagos. El hospedador intermediario sigue siendo una incógnita, lo cual impide que se pueda establecer la ruta exacta a partir de la cual habría pasado a infectar al ser humano. La enfermedad COVID-19 se caracteriza por tos, fiebre y disnea, con una sintomatología leve en la mayoría de los casos, y por afectar a adultos principalmente. Los cuadros más graves se han registrado en pacientes mayores de 60 años y/o con comorbilidades asociadas. La letalidad de COVID-19 informada inicialmente pareció ser menor al 5%. No obstante, la letalidad puede variar dependiendo de las características de la población. El nuevo virus se difunde persona-persona por vía aérea principalmente y existe posibilidad de transmisión asintomática. El período de incubación estimado varía entre 2 y 14 días. El diagnóstico de laboratorio se basas en la RT-PCR a tiempo real que se realiza en muestras respiratorias. Las medidas terapéuticas son básicamente de soporte ya que de momento ningún tratamiento farmacológico ha resultado definitivamente eficaz.
DOI : 10.36300/remasp.2020.061
Anahtar Kelimeler : coronavirus 2019-ncov, sars-cov-2, novel coronavirus, covid-19
ISSN: 2659-9716
Cilt: 4
Sayı: 2
Sayfa: 1 - 10
17
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Pathogens
Yazar(lar) :
Firas A. Rabi , Mazhar S. Al Zoubi , Ghena A. Kasasbeh , Dunia M. Salameh , Amjad D. Al-Nasser
Yıl :
2020
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far They were caused by a previously unknown coronavirus. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 ( COVID- 19), and the novel coronavirus was called SARS Coronavirus- 2 ( SARS- CoV- 2), emphasizing its close relationship to the 2002 SARS virus ( SARS- CoV). coronavirus covid-19 sars-cov-2
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.
DOI : 10.3390/pathogens9030231
Anahtar Kelimeler : coronavirus, covid-19, sars-cov-2, wuhan, pandemic
ISSN: 2076-0817
Cilt: 9
Sayı: 3
Sayfa: 231
Sınıflandırma :
18
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Public Health
Yazar(lar) :
Gyaneshwer Chaubey
Yıl :
2020
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.3389/fpubh.2020.00397
Anahtar Kelimeler : COVID-19, India, endogamy, disease susceptibility, herd immunity
ISSN: 2296-2565
Cilt: 8
Sınıflandırma :
19
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Immunology
Yazar(lar) :
Isabel Kinney Ferreira de Miranda Santos , Carlos Henrique Nery Costa
Yıl :
2020
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus COVID-19 Sars-CoV-2 coronavirus
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.3389/fimmu.2020.01739
Anahtar Kelimeler : COVID-19, Sars-CoV-2, coronavirus, antibodies, hydroxychloroquine
ISSN: 1664-3224
Cilt: 11
Sınıflandırma :
20
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Emerging Infectious Diseases
Yazar(lar) :
DirkJan Hijnen , Angelo Valerio Marzano , Kilian Eyerich , Corine GeurtsvanKessel , Ana Maria Giménez-Arnau , Pascal Joly , Christian Vestergaard , Michael Sticherling , Enno Schmidt
Yıl :
2020
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany During a meeting in Munich, Germany, a presymptomatic attendee with severe acute respiratory syndrome coronavirus 2 infected at least 11 of 13 other participants Although 5 participants had no or mild symptoms, 6 had typical coronavirus disease, without dyspnea. COVID-19 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
During a meeting in Munich, Germany, a presymptomatic attendee with severe acute respiratory syndrome coronavirus 2 infected at least 11 of 13 other participants. Although 5 participants had no or mild symptoms, 6 had typical coronavirus disease, without dyspnea. Our findings suggest hand shaking and face-to-face contact as possible modes of transmission.
DOI : 10.3201/eid2608.201235
Anahtar Kelimeler : COVID-19, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses
Cilt: 26
Sayı: 8
Sayfa: 1935 - 1937
Sınıflandırma :
21
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Nefrología (English Edition)
Yazar(lar) :
María Dolores Arenas , Judit Villar , Cristina González , Higinio Cao , Silvia Collado , Marta Crespo , Juan Pablo Horcajada , Julio Pascual
Yıl :
2020
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units The current outbreak of SARS- CoV- 2 represents a special risk for renal patients due to their comorbidities and advanced age. particular in hemodialysis units, with the objective of early identification of patients who meet the definition of a suspected case of infection by SARS- CoV Resumen: La epidemia de SARS- CoV- 2 representa un riesgo especial para los pacientes renales por su condición de personas con comorbilidades y edad avanzada SARS-CoV-2 COVID-19 Coronavirus
Yayıncı Web Sitesi
Kaydet Alıntıla
The current outbreak of SARS-CoV-2 represents a special risk for renal patients due to their comorbidities and advanced age. The usual performance of hemodialysis treatment s in collective rooms increases the risk. The specific information at this time in this regard is very limited. This manuscript includes a proposal for action to prevent infection in the Nephrology Services, and in particular in hemodialysis units, with the objective of early identification of patients who meet the definition of a suspected case of infection by SARS-CoV-2 and propose circuits and mechanisms to carry out hemodialysis treatments. They are recommendations in continuous review and can be modified if the epidemiological situation, the diagnostic and therapeutic options so require. Resumen: La epidemia de SARS-CoV-2 representa un riesgo especial para los pacientes renales por su condición de personas con comorbilidades y edad avanzada, y por la realización del tratamiento de hemodiálisis en salas colectivas. La información específica en el momento actual al respecto es muy limitada. El presente manuscrito recoge una propuesta de actuación para prevenir la infección en los Servicios de Nefrología, y en particular en las Unidades de Hemodiálisis, con el objetivo de identificar precozmente aquellos pacientes que cumplan con la definición de caso sospechoso de infección por el SARS-CoV-2 y proponer circuitos y mecanismos para administrarles el tratamiento con hemodiálisis. Son recomendaciones en continua revisión y podrán ser modificadas si la situación epidemiológica y las opciones diagnóstico-terapéuticas así lo requieren.
Anahtar Kelimeler : Hemodiálisis, SARS-CoV-2, COVID-19, Coronavirus
ISSN: 2013-2514
Cilt: 40
Sayı: 3
Sayfa: 258 - 264
22
ORIGEN PROBABLE Y TRANSMISIÓN ENTRE ESPECIES DEL SARS-CoV-2
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
infoANALITÍCA
Yazar(lar) :
Johanna Alvarado-Ortiz , Lorena Meneses Olmedo , Fabio Idrovo-Espín
Yıl :
2020
ORIGEN PROBABLE Y TRANSMISIÓN ENTRE ESPECIES DEL SARS-CoV-2 Posteriormente, se determinó que el responsable fue un coronavirus, que se llamó SARS- CoV- 2, cuya rápida propagación produjo la pandemia de la enfermedad coronavirus disease 19 ( COVID- 19). en algunos organismos hospederos infectados por diferentes cepas de coronavirus incluyendo el SARS- CoV- 2. Coronavirus
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
A finales del año pasado se reportaron casos de pacientes con neumonía atípica en Wuhan, Provincia de Hubei, China. La mayoría de pacientes iniciales trabajaban, vivían o eran consumidores de productos del mercado mayorista de mariscos lo que sugirió un posible contagio de un patógeno de origen animal al ser humano. Posteriormente, se determinó que el responsable fue un coronavirus, que se llamó SARS-CoV-2, cuya rápida propagación produjo la pandemia de la enfermedad coronavirus disease 19 (COVID-19). La enfermedad es actualmente motivo de preocupación e intensa investigación a nivel mundial. Se han postulado teorías sobre el origen del coronavirus siendo la más aceptada que el virus proviene del pangolín malayo. Con la finalidad de reforzar esta teoría, en la presente investigación, a partir de secuencias nucleotídicas de dominio público, se seleccionaron fragmentos de secuencias nucleotídicas que codifican para la espícula glicoprotéica superficial de coronavirus en algunos organismos hospederos infectados por diferentes cepas de coronavirus incluyendo el SARS-CoV-2. De la filogenia y análisis de secuencias de amino ácidos de la espícula glicoprotéica del coronavirus se encontró posibles eventos de transmisión entre especies del virus responsable de la enfermedad incluyendo el ser humano.
DOI : 10.26807/ia.v8i2.142
Anahtar Kelimeler : Coronavirus, transmisión entre especies, secuencias
Cilt: 8
Sayı: 2
23
COVID-19: the novel SARS-CoV-2 pandemic
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Peruana de Medicina Experimental y Salud Pública
Yazar(lar) :
Roberto Alfonso Accinelli , Cristian Mingxiong Zhang Xu , Jia-Der Ju Wang , José Miguel Yachachin-Chávez , Jaime Augusto Cáceres-Pizarro , Karla Beatriz Tafur-Bances , Roberto Gabriel Flores-Tejada , Alejandra del Carmen Paiva-Andrade
Yıl :
2020
COVID-19: the novel SARS-CoV-2 pandemic During the first weeks of 2020, cases of SARS- CoV- 2 began to be reported outside of China, with a rapid increase in cases and deaths worldwide. SARS- CoV- 2 is a positive single-stranded RNA virus, encased in a lipid bilayer derived from the host cell membrane and consists of four structural proteins are no large-scale studies regarding the use of chloroquine / hydroxychloroquine, due to the global situation, its use has been authorized for its anti- SARS- CoV infecciones por coronavirus
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
During the first weeks of 2020, cases of SARS-CoV-2 began to be reported outside of China, with a rapid increase in cases and deaths worldwide. SARS-CoV-2 is a positive single-stranded RNA virus, encased in a lipid bilayer derived from the host cell membrane and consists of four structural proteins (S, M, E and N), plus a haemagglutinin-sterase. The binding of the S protein to the ECA2 receptor allows the entry of the virus into the host cell and is a potential therapeutic target. 81% of patients develop mild symptoms, 14% have severe symptoms and 5% require intensive care management. Fever is the most frequent symptom, followed by cough and dyspnea. Most patients do not present leukocytosis, but they do present lymphopenia with sputum cultures that do not show other pathogens. In lung biopsies of severe patients, the most noticeable finding is diffuse alveolar damage. Radiologically, ground glass and alveolar patterns are observed; the lesions being predominantly basal, subpleural, and posterior, with a multifocal peripheral distribution, more affecting the right lower lobe. There is a marked inflammatory response, up to the cytokine storm, in which anti-inflammatory treatment with pulse therapy with methylprednisolone would be indicated. Although there are no large-scale studies regarding the use of chloroquine / hydroxychloroquine, due to the global situation, its use has been authorized for its anti-SARS-CoV-2 and anti-inflammatory effect, which can be potentiated with the use of azithromycin.
DOI : 10.17843/rpmesp.2020.372.5411
Anahtar Kelimeler : síndrome respiratorio agudo grave, neumonía viral, infecciones por coronavirus, pandemia
Cilt: 37
Sayı: 2
Sayfa: 302 - 11
Sınıflandırma :
24
SARS-CoV-2: characteristics and current advances in research
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Virology Journal
Yazar(lar) :
Yicheng Yang , Zhiqiang Xiao , Kaiyan Ye , Xiaoen He , Bo Sun , Zhiran Qin , Jianghai Yu , Jinxiu Yao , Qinghua Wu , Zhang Bao , Wei Zhao
Yıl :
2020
SARS-CoV-2: characteristics and current advances in research Abstract Coronavirus disease 2019 ( COVID- 19) caused by SARS- CoV- 2 infection has spread rapidly across the world and become an international public health We present a comprehensive survey of the latest coronavirus— SARS- CoV- 2—from investigating its origin and evolution alongside SARS- CoV. Meanwhile, pathogenesis, cardiovascular disease in COVID- 19 patients, myocardial injury and venous thromboembolism induced by SARS- CoV- 2 as well as the SARS-CoV-2 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has spread rapidly across the world and become an international public health emergency. Both SARS-CoV-2 and SARS-CoV belong to subfamily Coronavirinae in the family Coronaviridae of the order Nidovirales and they are classified as the SARS-like species while belong to different cluster. Besides, viral structure, epidemiology characteristics and pathological characteristics are also different. We present a comprehensive survey of the latest coronavirus—SARS-CoV-2—from investigating its origin and evolution alongside SARS-CoV. Meanwhile, pathogenesis, cardiovascular disease in COVID-19 patients, myocardial injury and venous thromboembolism induced by SARS-CoV-2 as well as the treatment methods are summarized in this review.
DOI : 10.1186/s12985-020-01369-z
Anahtar Kelimeler : SARS-CoV-2, COVID-19, Cytokine storm, Cardiovascular disease, Myocardial injury, Venous thromboembolism
ISSN: 1743-422X
Cilt: 17
Sayı: 1
Sayfa: 1 - 17
Sınıflandırma :
25
Koroonaviiruse SARS-CoV-2 algusfaasi vastukaja (sotsiaal)meedias
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Mäetagused
Yazar(lar) :
Maris Kuperjanov
Yıl :
2020
Koroonaviiruse SARS-CoV-2 algusfaasi vastukaja (sotsiaal)meedias The aim of the article is to give an overview of the first month of the novel coronavirus outbreak and public reactions to the news in the media comments The pandemic is still in its initial phase at the time of the publishing of the article and the knowledge about virus SARS- CoV- 2 and disease COVID- 19 is of more prominent topics and examples of the outbreak from social media environments during the initial phase of international awareness of the novel coronavirus coronavirus
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
The aim of the article is to give an overview of the first month of the novel coronavirus outbreak and public reactions to the news in the media comments and social media environments. The pandemic is still in its initial phase at the time of the publishing of the article and the knowledge about virus SARS-CoV-2 and disease COVID-19 is increasing on a daily basis. During the first month of the virus outbreak the growing flow of information and rapid escalation of the situation made the topic more noticeable in both the media and social media and thus provided a fertile basis for jokes and internet memes, legends, fake news, misinformation and conspiracy theories, etc., as was the case with the former bigger epidemics and pandemics. As it has also been observed previously, the consequences of some fake news, misinformation and conspiracy theories may often be more harmful for the society than the disease itself. Several motives and storylines are universal and surge as similar situations arise both in Estonia and in the rest of the world. The article also presents a small selection of more prominent topics and examples of the outbreak from social media environments during the initial phase of international awareness of the novel coronavirus.
DOI : 10.7592/MT2020.76.kuperjanov
Anahtar Kelimeler : conspiracy theories, coronavirus, internet memes, public health, social media
Cilt: 76
Sayfa: 5 - 28
Sınıflandırma :
26
Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Borneo Journal of Pharmacy
Yazar(lar) :
Vidhan Chand Bala , Punet Kumar
Yıl :
2020
Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak of 5,204,508 confirmed cases, with 212 countries being affected by the novel coronavirus. 2019 novel coronavirus ( SARS- CoV- 2) is that the seventh member The SARS- CoV- 2 may be a β- CoV of group 2B there is 70% comparability in genetic sequence to SARS- CoV. With whole-genome sequences of SARS- CoV- 2 is 96% comparatively at the whole-genome level to a bat coronavirus. covid-19 coronavirus sars-cov
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational report from May 22nd, 2020, globally, there is a complete of 5,204,508 confirmed cases, with 212 countries being affected by the novel coronavirus. 2019 novel coronavirus (SARS-CoV-2) is that the seventh member of the family of coronaviruses is enveloped viruses with a positive sense, single-stranded RNA genome. The SARS-CoV-2 may be a β-CoV of group 2B there is 70% comparability in genetic sequence to SARS-CoV. The source of the new coronavirus infection has been resolved as bats. With whole-genome sequences of SARS-CoV-2 is 96% comparatively at the whole-genome level to a bat coronavirus. Mechanisms of transmission are concluded to incorporate contact, droplet, and possibly airborne under certain circumstances supported ancient experiences associated with SARS-CoV outbreaks. Although antiretroviral therapy is being widely used everywhere the globe for such patents, effects at finding a SARS-CoV vaccine haven’t succeeded so far.
DOI : 10.33084/bjop.v3iSpecial-1.1412
Anahtar Kelimeler : covid-19, coronavirus, 2019-ncov, sars-cov, mers-cov
ISSN: 2621-4814
Cilt: 3
Sayı: Special-1
Sayfa: 103 - 120
Sınıflandırma :
27
SARS-CoV-2 and COVID-19: The most important research questions
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Cell & Bioscience
Yazar(lar) :
Kit-San Yuen , Zi -Wei Ye , Sin-Yee Fung , Chi-Ping Chan , Dong-Yan Jin
Yıl :
2020
SARS-CoV-2 and COVID-19: The most important research questions Abstract Coronavirus disease 2019 ( COVID- 19) caused by severe acute respiratory syndrome coronavirus 2 ( SARS- CoV- 2) is an ongoing global health emergency SARS-CoV-2 COVID-19 2019 novel coronavirus (2019-nCoV)
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. Here we highlight nine most important research questions concerning virus transmission, asymptomatic and presymptomatic virus shedding, diagnosis, treatment, vaccine development, origin of virus and viral pathogenesis.
DOI : 10.1186/s13578-020-00404-4
Anahtar Kelimeler : SARS-CoV-2, COVID-19, 2019 novel coronavirus (2019-nCoV), Novel coronavirus pneumonia (NCP)
ISSN: 2045-3701
Cilt: 10
Sayı: 1
Sayfa: 1 - 5
28
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
PLoS Pathogens
Yazar(lar) :
Ping Liu , Jing-Zhe Jiang , Xiu-Feng Wan , Yan Hua , Linmiao Li , Jiabin Zhou , Xiaohu Wang , Fanghui Hou , Jing Chen , Jiejian Zou , Jinping Chen
Yıl :
2020
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Recent studies showed that SARS- CoV- 2 was likely originated from bats, but its intermediate hosts are still largely unknown. The molecular and phylogenetic analyses showed that this pangolin coronavirus (pangolin- CoV-2020) is genetically related to the SARS- CoV- 2 as well as a group of bat coronaviruses but do not support the SARS- CoV- 2 emerged directly from the pangolin- CoV-2020.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The outbreak of a novel corona Virus Disease 2019 (COVID-19) in the city of Wuhan, China has resulted in more than 1.7 million laboratory confirmed cases all over the world. Recent studies showed that SARS-CoV-2 was likely originated from bats, but its intermediate hosts are still largely unknown. In this study, we assembled the complete genome of a coronavirus identified in 3 sick Malayan pangolins. The molecular and phylogenetic analyses showed that this pangolin coronavirus (pangolin-CoV-2020) is genetically related to the SARS-CoV-2 as well as a group of bat coronaviruses but do not support the SARS-CoV-2 emerged directly from the pangolin-CoV-2020. Our study suggests that pangolins are natural hosts of Betacoronaviruses. Large surveillance of coronaviruses in pangolins could improve our understanding of the spectrum of coronaviruses in pangolins. In addition to conservation of wildlife, minimizing the exposures of humans to wildlife will be important to reduce the spillover risks of coronaviruses from wild animals to humans.
DOI : 10.1371/journal.ppat.1008421
Cilt: 16
Sayı: 5
Sayfa: e1008421
Sınıflandırma :
29
SARS-CoV-2 Persistence: Data Summary up to Q2 2020
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Yazar(lar) :
Gabriele Cervino , Luca Fiorillo , Giovanni Surace , Valeria Paduano , Maria Teresa Fiorillo , Rosa De Stefano , Riccardo Laudicella , Sergio Baldari , Michele Gaeta , Marco Cicciù
Yıl :
2020
SARS-CoV-2 Persistence: Data Summary up to Q2 2020 The coronavirus pandemic is causing confusion in the world. This confusion also affects the different guidelines adopted by each country. The persistence of Coronavirus, responsible for coronavirus disease 2019 ( Covid- 19) has been evaluated by different articles, but it is still not well-defined The aim of this manuscript is to underline new Coronavirus persistence features on different environments and surfaces. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus pandemic is causing confusion in the world. This confusion also affects the different guidelines adopted by each country. The persistence of Coronavirus, responsible for coronavirus disease 2019 (Covid-19) has been evaluated by different articles, but it is still not well-defined, and the method of diffusion is unclear. The aim of this manuscript is to underline new Coronavirus persistence features on different environments and surfaces. The scientific literature is still poor on this topic and research is mainly focused on therapy and diagnosis, rather than the characteristics of the virus. These data could be an aid to summarize virus features and formulate new guidelines and anti-spread strategies.
DOI : 10.3390/data5030081
Anahtar Kelimeler : COVID-19, virus, epidemiology, surfaces, infection risk, public health
ISSN: 2306-5729
Cilt: 5
Sayı: 81
Sayfa: 81
Sınıflandırma :
Viroloji %42
30
Disinfection measures and control of SARS-COV-2 transmission
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Global Biosecurity
Yazar(lar) :
Phelipe Magalhães Duarte , Vivian Tallita Pinheiro de Santana
Yıl :
2020
Disinfection measures and control of SARS-COV-2 transmission A new virus, classified as a variant of the coronavirus that causes severe acute respiratory syndrome ( SARS), is severe acute respiratory syndrome coronavirus 2 or SARS- CoV- 2. covid-19 coronavirus
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
A new virus, classified as a variant of the coronavirus that causes severe acute respiratory syndrome (SARS), is severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2. The virus can be inactivated by heating at 56 ºC for 30 minutes and by using lipid solvents such as ethanol (> 75%), isopropanol (> 70%), formaldehyde (> 0.7%), povidone iodine (> 0, 23%), sodium hypochlorite (> 0.21%), or hydrogen peroxide (> 0.5%), but not chlorhexidine. Another approach is to use a footbath at the entrance of a house. The use of irradiation with ultraviolet light for 60 minutes resulted in the inactivation of several coronaviruses.
DOI : 10.31646/gbio.64
Anahtar Kelimeler : infectious disease, covid-19, disinfectants, respiratory infection, coronavirus
ISSN: 2652-0036
Cilt: 1
Sayı: 3
Sınıflandırma :

Yayın Yılı

Sınırla

Doküman Türü
Tümü

Veri Tabanı
Tümü

  Tüm Veritabanlarını Gör

Dergi İsmi
Tümü

Disiplin
Tümü

Disipline Göre İlgililik

Alt Disiplin
Tümü

Konu
Tümü

Yayıncı
Tümü

Lisan
Tümü

X
Filtreler